Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial

IMPORTANCE: Apatinib is a novel treatment option for chemotherapy-refractory advanced gastric cancer (GC), but it has not been evaluated in patients with locally advanced GC. OBJECTIVE: To investigate the effectiveness and safety of apatinib combined with S-1 plus oxaliplatin (SOX) as a neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jian-Xian, Xu, Yan-Chang, Lin, Wei, Xue, Fang-Qin, Ye, Jian-Xin, Zang, Wei-Dong, Cai, Li-Sheng, You, Jun, Xu, Jian-Hua, Cai, Jian-Chun, Tang, Yi-Hui, Xie, Jian-Wei, Li, Ping, Zheng, Chao-Hui, Huang, Chang-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271357/
https://www.ncbi.nlm.nih.gov/pubmed/34241629
http://dx.doi.org/10.1001/jamanetworkopen.2021.16240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271357/
https://www.ncbi.nlm.nih.gov/pubmed/34241629
http://dx.doi.org/10.1001/jamanetworkopen.2021.16240

Ejemplares similares